-Reuters
B of A Securities Initiates Coverage On Rani Therapeutics Hldgs with Buy Rating, Announces Price Target of $23
B of A Securities initiates coverage on Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy rating and announces Price Target of $23.